Sino Biological Inc.’s Net Profit Dropped 50.4% in First Three Quarters of 2022
Listen to the full version

Sino Biological Inc. (北京义翘神州科技股份有限公司) (301047.SZ) reported a net profit of 275.9 million yuan in the first three quarters of 2022, down 50.4% year-on-year.
Meanwhile, the company posted 430.3 million yuan in revenue, down 47.1% year-on-year.
At the end of the reporting period, it had 6.5 billion yuan in total assets and 170.8 million yuan in total liabilities, with a liability-to-asset ratio of 2.6%.
Unlock exclusive discounts with a Caixin group subscription — ideal for teams and organizations.
Subscribe to both Caixin Global and The Wall Street Journal — for the price of one.
- PODCAST
- MOST POPULAR